SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-11-053749
Filing Date
2011-09-19
Accepted
2011-09-19 16:42:42
Documents
8
Period of Report
2011-11-07
Effectiveness Date
2011-09-19

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT v235082_def14a.htm DEF 14A 613004
2 GRAPHIC line.gif GRAPHIC 43
3 GRAPHIC logo_protalix.jpg GRAPHIC 9522
4 GRAPHIC sig_david-aviezer.jpg GRAPHIC 4695
5 GRAPHIC sig_yossimaimon.jpg GRAPHIC 2874
6 GRAPHIC spacer.gif GRAPHIC 43
7 GRAPHIC v235082_pc1.jpg GRAPHIC 165391
8 GRAPHIC v235082_pc2.jpg GRAPHIC 342998
  Complete submission text file 0001144204-11-053749.txt   1339415
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33357 | Film No.: 111097667
SIC: 2836 Biological Products, (No Diagnostic Substances)